The Hong Kong Marrow Match Foundation was established as a charity in 1991 to set up and operate an unrelated bone marrow donor registry for the largely Chinese population of Hong Kong and to assist patients requiring bone marrow transplantation to locate donors in Hong Kong or elsewhere. In the 10 years that followed, the registry has recruited over 42 000 predominantly Chinese donors and has provided donors for 150 patients in Hong Kong and overseas requiring transplantation. This report describes the current status of the Foundation.
The Hong Kong Marrow Match Foundation ('HKMMF' -'the Foundation') was established as a charity in 1991 to set up and operate an unrelated bone marrow donor registry for the largely Chinese population of Hong Kong. The Foundation also functions as a local hub to find overseas donors for patients who are unable to find a suitable donor locally and to co-ordinate the provision of marrow to patients overseas. This report describes the current status of the Foundation.
The population
Hong Kong is located to the south of mainland China and has a population of over 6.5 million, of whom more than 95% are Chinese. Of these, the majority were either born in Hong Kong or Guangdong Province in southern China, or are the first or second generation offspring of people born there. The population is loosely referred to as 'southern Chinese' to distinguish it from Chinese originating elsewhere in China who have slightly different genetic, physical and linguistic characteristics. The term 'Cantonese' is also used to refer to both the population and the predominant Chinese dialect spoken by people living in Hong Kong and Guangdong Province.
Early history
The first related bone marrow transplant in Hong Kong was performed at Queen Mary Hospital in May 1990 when a 26-year-old Chinese patient with acute myeloid leukaemia received marrow from her brother. Even at that early stage, initial approaches to overseas donor registries had shown that it was difficult for Hong Kong patients to find suitable donors overseas because of the unique genetic characteristics of the Hong Kong population. It was therefore decided to set up a charitable foundation in Hong Kong to establish and operate a registry of primarily Chinese donors for the local population. The Hong Kong Marrow Match Foundation was established for this purpose in September 1991.
The first activity of the new Foundation was to co-ordinate a high-profile recruitment campaign to find a donor for a 16-month-old Chinese boy suffering from familial haemophagocytic lymphohistiocytosis who had come to Hong Kong from Canada with his parents in search of a donor. Over 9500 volunteers came forward to donate blood samples for this campaign in a single weekend in November 1991 and formed the basis of the Foundation's registry.
Management
The Foundation is managed by a Board of Governors made up of both medically qualified and non-medical members of the Hong Kong community. An Executive Committee drawn from the Board of Governors oversees the day-today activities of the Foundation.
The Foundation currently employs only four paid office staff and relies heavily on the services of volunteers for its major donor recruitment and fund-raising activities.
Funding for the registry is provided exclusively from charitable donations. The Foundation does not receive any funding from the government or government affiliated organisations.
Bone Marrow Transplantation

Accommodation
Initially, the Foundation shared accommodation with the Tissue Typing Laboratory at Queen Mary Hospital, but later moved into a leasehold office property in 1996.
Donor recruitment and selection
The Foundation accepts donors aged between 18 and 55 years and retains them until their 60th birthday. There is an annual recruitment target of 2000 new donors and the Foundation tries to arrange at least one high-profile recruitment campaign each year, usually with the assistance of a major newspaper. Throughout the year, the Foundation holds smaller campaigns at the request of organisations such as corporate groups, universities, community and church groups, etc., often in conjunction with the Red Cross Blood Transfusion mobile blood collection visits. The Foundation enjoys excellent collaboration with the Hong Kong Red Cross Blood Transfusion Service, and walk-in donors are encouraged to enroll as marrow donors on specified days at designated Red Cross locations throughout Hong Kong.
All donors are required to complete a health questionnaire at the time of recruitment. In practice, few applicants are rejected on the basis of responses to the health questionnaire alone as the Foundation takes the view that significant medical problems will be identified at the time of physical examination if the donor is recalled for a specific patient. In addition, there are cultural issues involved in the decision not to screen out donors at the time of recruitment, since to reject an offer of a significant charitable gesture (in this case to join the marrow donor registry) could be interpreted as insulting to the potential donor.
Physical examinations are not performed unless a donor has been identified as a probable donor for a specific patient on the basis of HLA typing. Of 114 potential donors evaluated up until 30 September 2001, only four were rejected because of medical problems at the physical examination stage: one with a psychiatric disorder, one with severe hypertension and a family history of cerebrovascular disease, one who was found to be a hepatitis surface antigen carrier, and one with iron deficiency anaemia. In the latter case, the potential donor's twin sister was eventually selected as the marrow donor.
Infectious disease serology is not performed until a potential donor is evaluated at the physical examination stage. Hepatitis B surface antigen is of particular relevance as its prevalence in the general population is around 10% and the prevalence of antibody is around 40%. Infectious disease serology also covers hepatitis C virus and human immunodeficiency virus although these are not major considerations since their prevalence in the general population is less than 1%.
Donor information is completely removed from the registry if the subject requests to be withdrawn. Less than 200 donors have requested to be withdrawn since the registry was first established.
Donors who cannot be contacted on three separate occasions are flagged on the database as 'non-active' but the information is retained in case contact is re-established at a later date. Several donors have donated marrow after being lost to contact by the Foundation for extended periods.
As of 30 September 2001, the database contained 42 853 donors of whom 39 251 (91.6%) were listed as 'active'. Of the 'active' donors, the male to female ratio was 1:1.18, and approximately 79% were aged 40 years or below (see Figure 1 ).
HLA typing
The Foundation does not have its own tissue-typing laboratory. Almost all blood samples from new donors and most samples for follow-up testing are currently sent to contract laboratories overseas. The Foundation does, however, make use of the Tissue Typing Laboratory in the Department of Pathology, Queen Mary Hospital, Hong Kong on a fee-forservice basis for confirmatory tissue typing and reference typing. This laboratory is accredited by the American Society of Histocompatibility and Immunogenetics.
All donors on the registry have HLA-A and -B phenotypes recorded, the great majority based on serological testing. Recently, the testing method has been replaced by PCR-based technology, and an increasing number of highresolution allelic typing results are now available. designation such as B40 without further subgroup information were counted as separate phenotypes from those containing the splits. Of the 6061 phenotypes detected, 3056 (50.4%) occurred only once, and 80.4% occurred five times or fewer. At the other end of the spectrum, 394 phenotypes (6.5%) occurred 20 or more times, and 58 (0.96%) occurred 100 or more times. The most common phenotype (A2, A11, B46, B75) occurred 655 times, corresponding to a phenotype frequency of 1.528%. Since less than 1% of our registered donors are non-Chinese, these figures provide a good indication of the heterogeneity of the Chinese population.
Provision of marrow for transplantation
The first unrelated bone marrow transplant using a donor from the Foundation's registry took place in April 1992. Five months later, the first bone marrow from a Hong Kong donor to be used for an overseas patient was sent to Australia.
As of 30 September 2001, a total of 110 transplants had been performed using donors from the HKMMF registry, 86 for recipients in Hong Kong and 24 for recipients overseas. In addition, as of that date, the Foundation had obtained bone marrow from overseas donors for 25 patients in Hong Kong. Annual transplantation statistics are shown in Figure 2 . Statistics on the origin and destination of marrow received from and sent overseas are shown in Tables  1 and 2 . 
Patient demographics
The age distribution of bone marrow transplant recipients arranged through the Foundation is shown in Figure 3 . The underlying diseases of these patients are shown in Figure  4 . Over 86% of recipients had some form of leukaemia.
Success in identifying donors
The month of sending the initial letter. Less than one in 30 donors decline the request for further blood testing. Searches are repeated monthly for patients who are unsuccessful in identifying a donor until the Foundation is requested by the referring physician to terminate the search.
In Table 3 we compare the annual growth of the donor pool with the percentage of searches for local patients in which a matched donor was eventually located. In our earlier publications we reported a success rate of around 40% in identifying donors from our registry for Hong Kong patients. As shown in Table 3 , there has been a significant increase in the success rate over the years as the size of the pool has increased, with an impressive peak of 84% in 1999.
This method of evaluating the success of the registry is necessarily crude. The figures shown for the number of matches represent the number of patients who eventually found a matched donor, not necessarily in the year in which Table  3 show a clear benefit in terms of improved search success as the number of donors on the registry has increased. Unfortunately, the success rate in identifying fully matched donors for overseas patients has been less encouraging. The most successful year was that ending on 30 September 2001 during which 28 out of 166 searches (16.9%) showed the presence of at least one matched donor. The least successful year was 1996 when only three out of 136 overseas patients (2.2%) found a matched donor. These figures do not take into consideration searches performed on-line through Bone Marrow Donors Worldwide.
Provision of cord blood for transplantation
When requested, the Foundation will assist transplant units in Hong Kong in obtaining cord blood for transplantation. As of 30 September 2001, the Foundation has assisted in obtaining cord blood for eight patients. Two of the cord blood donations were from the USA, and one each was obtained from Hong Kong, Australia, Belgium, Italy, The Netherlands and the UK.
Other affiliations
The Foundation became an International Donor Centre within the American National Marrow Donor Program (NMDP) in 1993 and is represented on the World Marrow Donor Association. In addition, the Foundation is a member of Bone Marrow Donors Worldwide, which allows overseas centres to search its registry on-line. Queen Mary Hospital and Prince of Wales Hospital, the two institutions at which bone marrow transplantation is performed in Hong Kong, are both recognised as Transplant Centres and Collection Centres by the NMDP.
Future directions
As the registry has grown over the years, so also has the number of patients who successfully find a matched donor from the registry. Because of the structure and funding arrangements of the health care system in Hong Kong, however, relatively few local patients are able to consider using a marrow donor from an overseas registry. Whilst the Foundation was able to obtain overseas marrow donors for 25 patients during its first 10 years, most of these were funded by other charitable agencies. Charitable funding of this sort cannot be relied upon indefinitely, and provides a strong justification for further increasing the size of the local donor pool in the future.
Like most registries elsewhere, one of the most urgent priorities for the Foundation in the immediate future must be to reduce the time taken to identify matched donors. The delays caused by retrospective DR typing are kept to a minimum, but there are persuasive reasons for substantially increasing the number of new donors on whom DR typing is performed prospectively. There could also be significant benefits, both financial and logistic, in performing the initial donor HLA typing in-house.
Since the Foundation operates on an entirely charitable basis, its most pressing challenge over the coming years must be to maintain adequate funding to ensure its continued existence.
Publications
The registry has been the subject of a number of publications, some of which are listed in Refs 1-9.
